Spain: coronary and structural heart interventions from 2010 to 2015
Bruno García Del Blanco1, Pilar Jiménez Quevedo, José D Diaz
1Interventional Cardiology, Hospital Vall d'Hebron, CIBER-CV, Barcelona, Spain.
Summary
The Spanish Society of Cardiology
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Catheterization
Background:
- The Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology has published annual reports since 1990.
- Data is voluntarily provided by 105-113 hospitals, covering 46.8 million inhabitants in 2015.
- Online data support has been available since 2010.
Purpose of the Study:
- To analyze trends in cardiac catheterization and interventional cardiology procedures in Spain.
- To report on the volume and types of diagnostic and interventional procedures performed.
- To assess the adoption of radial access and structural interventions.
Main Methods:
- Analysis of voluntarily submitted data from a national registry of cardiac catheterization procedures.
- Data collected from 105-113 participating hospitals.
- Statistical analysis of procedure volumes, patient demographics, and access site utilization.
Main Results:
- Diagnostic procedures increased, with coronary angiograms accounting for 86% of 145,836 procedures in 2015.
- Percutaneous coronary interventions reached 67,671 procedures, with 21.7% performed during acute myocardial infarction.
- Radial access utilization was high (73.8% diagnostic, 76.1% interventional).
- Structural interventions showed growth, including 1,586 TAVI and 334 LAA closure procedures in 2015.
Conclusions:
- Cardiac catheterization and interventional cardiology procedures have shown a significant increase in Spain.
- Radial access is the predominant approach for both diagnostic and interventional procedures.
- There is a notable evolution and increase in structural heart interventions.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
347
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
347
Coronary Artery Disease IV: Preventive Measures
776
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
776
Acute Coronary Syndrome IV: Interprofessional Care
349
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
349
Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Coronary Artery Disease II: Pathophysiology
817
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
817
Coronary Artery Disease III: Clinical Manifestations
485
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
485


